NCT02195557

Brief Summary

Retrospective collection of data, aimed at a better knowledge of the use of Synvisc® among the patients with knee osteoarthritis (OA) since at least three years.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2002

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2003

Completed
11.4 years until next milestone

First Submitted

Initial submission to the registry

July 18, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 21, 2014

Completed
Last Updated

July 22, 2014

Status Verified

July 1, 2014

Enrollment Period

11 months

First QC Date

July 18, 2014

Last Update Submit

July 21, 2014

Conditions

Osteoarthritis

Outcome Measures

Primary Outcomes (3)

  • Reason for prescription

    at least 3 years before start of observation period

  • Number of other treatments per patient

    antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs), specific symptomatic treatments and surgery

    at least 3 years of observation

  • Time between two treatments

    at least 3 years of observation

Study Arms (1)

Synvisc®

Drug: Synvisc®

Interventions

Synvisc®DRUG
Synvisc®

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

rheumatological practice

You may qualify if:

  • Patients with knee osteoarthritis using Synvisc® since at least three years

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis

Interventions

hylan

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2014

First Posted

July 21, 2014

Study Start

April 1, 2002

Primary Completion

March 1, 2003

Last Updated

July 22, 2014

Record last verified: 2014-07